Bioengineered lymphatic healing platform for breast cancer-related lymphedema
Official title: Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema
Funded at Rice University · NIH-11359627 · Data updated 2026-11-12
A new brainy hydrogel-based approach aims to help people who develop lymphedema after breast cancer by guiding and regenerating lymphatic vessels.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | June 20, 2025 |
| Project end | April 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $460,788 |
| NIH project number | 5R01HL179534-02 |
| Project ID | NIH-11359627 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with breast cancer-related lymphedema who are candidates for future regenerative therapies.
✕Less likely to help
People whose lymphedema is unrelated to breast cancer, or who have conditions that prevent lymphatic regeneration.
What this research studies
This project uses a 3D-printable alginate hydrogel layer, coated with an anti-fibrotic molecule, to recruit and reconstruct lymphatic vessels in affected regions. It combines programmable cell therapies within the hydrogel to promote lymphatic growth while reducing foreign-body reactions. The goal is to address the root causes of lymphedema instead of relying on lifelong compression, potentially lowering infection and hospitalization risks. The work is tested in preclinical models and focuses on translating these findings toward human treatment options.
Why it matters
Potential benefit: If successful, the platform could reduce or reverse breast cancer-related lymphedema, improving swelling, infections, and quality of life.
How similar studies have gone: Previous work shows promise in guiding lymphatic growth with hydrogels, but challenges remain in avoiding immune reactions and achieving durable regeneration.
Where this research is happening
-
Rice University
Houston, United States Active
Researchers
- Principal investigator: Veiseh, Omid — Rice University
- Study coordinator: Veiseh, Omid
Related research
Other NIH-funded projects on the same topics.
-
Why Black women have higher risk of arm swelling after breast cancer surgery
This project looks for cellular reasons why Black women are more likely to develop long-term arm swelling after lymph node removal for breast cancer.
-
A new treatment platform for breast cancer-related lymphedema
This study is testing a new gel treatment for breast cancer survivors who have lymphedema, aiming to help them feel better by improving lymphatic drainage and reducing symptoms in a less invasive way.
-
Understanding why Black women are more likely to develop lymphedema after breast cancer treatment
This study is looking at why Black women are more likely to develop lymphedema after breast cancer treatment, and it will follow women who have had surgery to remove lymph nodes to find out what factors might increase this risk, with the hope of improving prevention and treatment options for those affected.
-
Exploring lymphedema symptoms and lifestyle in breast cancer survivors who are nurses
This study is looking at how breast cancer-related lymphedema affects nurses who have survived breast cancer, focusing on their symptoms and daily challenges, to better understand their needs and improve support for them.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.